Filing Details
- Accession Number:
- 0001209191-20-045142
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-05 16:50:04
- Reporting Period:
- 2020-08-03
- Accepted Time:
- 2020-08-05 16:50:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645460 | Cue Biopharma Inc. | CUE | Pharmaceutical Preparations (2834) | 473324577 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1739130 | Anish Suri | C/O Cue Biopharma, Inc. 21 Erie Street Cambridge MA 02139 | President And Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-08-03 | 2,000 | $8.26 | 36,558 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-08-03 | 3,800 | $6.42 | 40,358 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-03 | 5,800 | $20.01 | 34,558 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-08-04 | 400 | $6.42 | 34,958 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-08-04 | 400 | $20.14 | 34,558 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-03 | 2,000 | $0.00 | 2,000 | $8.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-03 | 3,800 | $0.00 | 3,800 | $6.42 |
| Common Stock | Stock Option (right to buy) | Disposition | 2020-08-04 | 400 | $0.00 | 400 | $6.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | 2025-08-14 | No | 4 | M | Direct | |
| 146,200 | 2029-03-06 | No | 4 | M | Direct | |
| 145,800 | 2029-03-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 24, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.11 to$20.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges setforth in this footnote.
- This stock option grant becomes exercisable in eight equal semi-annual installments beginning November 14, 2018.
- This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 6, 2019.
Billionaire Hedge Funds
